Ignite part 5. Vaccination in SID: If, how and when?

Providing an insightful panel discussion on the complexities of vaccination in managing secondary immunodeficiencies (SID). Experts from various fields emphasise the need for personalised patient care, and further research to enhance vaccination strategies.

Using vaccination responses to diagnose and treat SID: the need for improved criteria and a deeper understanding of immune responses

A panel of experts explore the use of vaccination in identifying and managing secondary immunodeficiencies in this session. Discussions on the challenges in defining protective immune responses, the impact of COVID-19 on understanding immune responses, and the potential for vaccines to serve both diagnostic and therapeutic functions are key topics debated by the panel.

Challenges in timing, efficacy, and need for immunoglobulin replacement therapy and vaccination in SID patients

A continuation of the panel discussion, focusing on the practical application of vaccination in SID patients, including how vaccination responses might inform the duration of immunoglobulin replacement therapy and the broader role of vaccines in preventing infections among immunocompromised patients.